ArticleClinical and translational science2016

Patient-Level Adverse Event Patterns in a Single-Institution Study of the Multi-Kinase Inhibitor Sorafenib.

S Karovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.